Artrya (ASX:AYA) Selling and Marketing Expense : A$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Artrya Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Artrya's Selling and Marketing Expense for the six months ended in Dec. 2024 was A$0.00 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.00 Mil.

Artrya Selling and Marketing Expense Historical Data

The historical data trend for Artrya's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Selling and Marketing Expense Chart

Artrya Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Selling and Marketing Expense

1.70

0.21

0.09

Artrya Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Selling and Marketing Expense	Get a 7-Day Free Trial			-	-	-	-	-

Artrya Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Artrya Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Artrya's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Artrya Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Selling and Marketing Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1257 Hay Street, West Perth, Perth, WA, AUS, 6005

Website

https://www.artrya.com

Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines